Accessibility Menu
Siemens Healthineers Ag logo

Siemens Healthineers Ag(OTC) SMMNY

Market Cap$50.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+21%
5 Year-28%
1 Year-14%
1 Month+13%
$22.52
+0.09%
+0.02Today
Siemens Healthineers Ag last closing stock price
MetricPriceDate
Last closeUSD 22.522026-08-04
Siemens Healthineers Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+10.04%USD 20.462026-07-28
1 month+12.8%USD 19.962026-07-02
3 month+7.75%USD 20.902026-05-06
Year to date-12.07%USD 25.612025-12-31
1 year-13.65%USD 26.072025-08-04
3 year-11.02%USD 25.302023-08-04
5 year-28.4%USD 31.452021-08-05
Since inception+20.6%USD 18.652018-05-14

Siemens Healthineers Ag Financials at a Glance

Market Cap

$50.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€21.87B

Net Income (TTM)

€2.22B

EPS (TTM)

$1.15

P/E Ratio

19.54

Dividend

$0.59

Beta (Volatility)

0.77 (Low)

Price

$22.52

Volume

54,720

Open

$22.61

Previous Close

$22.52

Daily Range

$22.40 - $22.65

52-Week Range

$19.20 - $28.92

Estimated Earnings Date

Nov 5, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Siemens Healthineers Ag

Siemens Healthineers AG is a global leader in medical technology, providing a comprehensive suite of diagnostic and therapeutic products and services. The company operates across various international markets, focusing on enhancing healthcare delivery through innovative solutions.

Products and Services
  • Imaging systems including MRI, CT, and ultrasound technologies
  • In-vitro diagnostic products for laboratory and point-of-care settings
  • Oncology solutions and advanced therapies for minimally invasive procedures
Growth Outlook
  • Revenue of €5.77 billion reported in Q2 2026, showing strong demand
  • Net income of €514 million in Q2 2026, reflecting operational efficiency
  • Continued investment in R&D, with €495 million allocated in Q2 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of €22.5 billion, indicating robust growth
  • Net profit margin of 9.09% TTM, showcasing effective cost management
  • Dividend yield of 2.85% TTM, appealing for income-focused investors
Siemens Healthineers AG has established itself as a key player in the healthcare sector, driven by a commitment to innovation and quality. The company's diverse product offerings cater to a wide range of medical needs, positioning it well for future growth. Recent financial performance highlights a strong revenue trajectory and effective management of operational costs, making it an attractive option for potential investors. The focus on research and development ensures that Siemens Healthineers AG remains at the forefront of medical technology advancements, further solidifying its market position.
AI Generated • Jul 20, 2026

Industry

Healthcare Equipment and Supplies

Employees

74,300

CEO

Bernhard Montag, PhD

Headquarters

Forchheim, BV 91301, DE

SMMNY Financials

Key Financial Metrics (TTM)

Gross Margin

39.02%

Operating Margin

14.84%

Net Income Margin

9.55%

Return on Equity

12.00%

Return on Capital

8.33%

Return on Assets

4.84%

Earnings Yield

5.12%

Dividend Yield

2.64%

Payout Ratio

50.52%

Stock Overview

Market Cap

$50.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.24B

Volume

54.72K

Avg. Volume

140.43K

Financials (TTM)

Gross Profit

€9.05B

Operating Income

€3.18B

EBITDA

€4.46B

Operating Cash Flow

€3.11B

Capital Expenditure

-€819.69M

Free Cash Flow

€2.29B

Cash & ST Invst.

€2.36B

Total Debt

€15.00B

Siemens Healthineers Ag Performance Analysis

Siemens Healthineers Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 23,481,935,0269.2%
20232023-09-30EUR 23,108,225,748-1.6%
20242024-09-30EUR 24,240,655,8064.9%
20252025-09-30EUR 25,806,913,8406.5%
Siemens Healthineers Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-12.0%
Q12025-12-317.5%
Q22026-03-317.9%
Q32026-06-30-0.2%
Siemens Healthineers Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 0.984.5%
20232023-09-30EUR 0.72-26.7%
20242024-09-30EUR 0.9430.9%
20252025-09-30EUR 1.0512.3%
Siemens Healthineers Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-306.1%
Q12025-12-31-23.1%
Q22026-03-31-42.5%
Q32026-06-30160.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

€5.76B

+1.8%

Gross Profit

€2.45B

+12.3%

Gross Margin

42.51%

N/A

Market Cap

$50.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$681.05K

N/A

Employees

74,000

N/A

Net Income

€669.00M

+21.2%

EBITDA

€1.25B

+3.4%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

€2.36B

-0.6%

Total Debt

€15.00B

-4.4%

Accounts Receivable

€6.56B

+5.0%

Inventory

€4.72B

+7.4%

Long Term Debt

€11.49B

-1.4%

Short Term Debt

€3.51B

-13.2%

Return on Assets

4.84%

N/A

Return on Invested Capital

10.46%

N/A

Free Cash Flow

€1.02B

+33.7%

Operating Cash Flow

€1.23B

+28.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHGCYChugai Pharmaceutical Co., Ltd.
$21.20+0.28%
SONVYSonova Holding AG
$57.18+1.17%
CSLLYCSL Limited
$22.96+5.42%
ESLOFEssilorLuxottica S.A.
$196.25-1.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About SMMNY

What is the current price of Siemens Healthineers Ag?

Siemens Healthineers Ag is trading at $22.52 per share.

What is the 52-week range for Siemens Healthineers Ag?

Over the past 52 weeks, Siemens Healthineers Ag has traded between $19.20 and $28.92.

How much debt does Siemens Healthineers Ag have?

As of the most recent reporting period, Siemens Healthineers Ag reported total debt of €17.15B.

How much cash does Siemens Healthineers Ag have on hand?

Siemens Healthineers Ag reported €2.70B in cash and cash equivalents in its most recent financial results.

What is Siemens Healthineers Ag’s dividend yield?

Siemens Healthineers Ag currently has a dividend yield of 2.64%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.